Search

Author/Creator Lukas, M

3. DOP027 Efficacy and safety of an additional 8 weeks of tofacitinib induction therapy: Results of the OCTAVE open study for tofacitinib 8-week induction non-responders. (16th January 2018)

Authors:
Feagan, B G; Dubinsky, M C; Lukas, M; Quirk, D; Nduaka, C I; Maller, E; Lawendy, N; Kayhan, C; Wang, W; Chan, G; Su, C
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 1(2018:Jan.)Supplement 1
Page Start:
S050
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. DOP43 Long-term efficacy of tofacitinib in patients who received extended induction therapy: results of the OCTAVE open study for tofacitinib delayed responders. (25th January 2019)

Authors:
Rubin, D T; Dubinsky, M C; Lukas, M; Quirk, D; Nduaka, C I; Maller, E; Lawendy, N; Kayhan, C; Fan, H; Woodworth, D A; Chan, G; Su, C
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S050
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. (15th February 2006)

Authors:
Caprilli, R; Gassull, M A; Escher, J C; Moser, G; Munkholm, P; Forbes, A; Hommes, D W; Lochs, H; Angelucci, E; Cocco, A; Vucelic, B; Hildebrand, H; Kolacek, S; Riis, L; Lukas, M; de Franchis, R; Hamilton, M; Jantschek, G; Michetti, P; O'Morain, C
Other Names:
group-author.
Journal:
Gut
Issue:
Volume 55(2006)Supplement 1
Page Start:
i36
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus. (July 2022)

Authors:
Ananthakrishnan, Ashwin N; Kaplan, Gilaad G; Bernstein, Charles N; Burke, Kristin E; Lochhead, Paul J; Sasson, Alexa N; Agrawal, Manasi; Tiong, Jimmy Ho Tuan; Steinberg, Joshua; Kruis, Wolfgang; Steinwurz, Flavio; Ahuja, Vineet; Ng, Siew C; Rubin, David T; Colombel, Jean-Frederic; Gearry, Richard...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 7(2022)
Page Start:
666
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. P138 Prediction model to safely cease anti-TNF therapy in Crohn's disease: individual patient data meta-analysis (IPD-MA). (25th January 2019)

Authors:
Pauwels, R W M; van der Woude, C J; Nieboer, D; Steyerberg, E W; Casanova, M J; Gisbert, J P; Lobo, A J; Lees, C W; Kennedy, N A; Molnár, T; Szánto, K; Louis, E; Mary, J-Y; Lukas, M; Duijvestein, M; Bots, S; D'Haens, G R A M; de Vries, A C
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S158
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗